menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

MabVax Therapeutics Holdings, I (MBVX)
0.88 0.014 (1.66%)  01-19 15:58
Open: 0.8709 Prev Close: 0.8656
High: 0.9199 Low: 0.851
Volume: 148,142 Market Cap: 18M
Year High: 3.57 Year Low: 0.43
Stock Technical Analysis
Overall       
Targets Six months: 2.2625    One year: 2.6864
Supports Support1: 1.3500   Support2: 1.1232
Resistances Resistance1: 1.9371    Resistance2: 2.3000 
Pivot Point 1.4612 
Moving Averages MA(5): 1.4300      MA(20): 1.5009 

MA(100): 2.1344  -1     MA(250): 3.3112 
MACD MACD(12,26): -0.092      Signal(12,26,9): -0.100 
Stochastic Oscillator %K(14,3): 16.667      %D(3): 20.556 
RSI RSI(14): 37.998 
52-Week High: 6.0500  Low: 1.3500  Change(%): -68
Average Volume(K) 3-Month: 82  10-Days: 67
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BEARISH in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed above bottom band by 16.4%; Bollinger Bands are 59.2% narrower than normal.The narrow width of the bands suggests low volatility as compared to MBVX's normal range. The bands have been in this narrow range for 4 bars. This is often a sign that a market may be about to initiate a new trend.

Stoxline

Stock Chart

Top 100 stocks

Stock News
MabVax Therapeutics Holdings, Inc. Provides Business Strategy Update
Tue, 16 Jan 2018 12:22:30 GMT

MabVax Therapeutics Holdings, Inc. Announces $1.25 Million Registered Direct ...
Fri, 22 Sep 2017 19:30:00 GMT

MabVax Therapeutics Holdings, Inc. Announces $500000 Registered Direct Offering
Wed, 11 Oct 2017 11:48:45 GMT

MabVax Therapeutics Holdings, Inc. Provides Corporate Overview and Business ...
Tue, 17 Oct 2017 11:16:25 GMT

MabVax Therapeutics Announces Completion of Enrollment and Initial Patient ...
Wed, 20 Dec 2017 12:00:00 GMT

MabVax Therapeutics Holdings Inc.
Sat, 11 Oct 2014 22:22:54 GMT

Mabvax Therapeutics Inc (NASDAQ:MBVX) On The Final Stages Of Dosing And ...
Fri, 19 Jan 2018 13:41:15 GMT

MabVax Therapeutics Announces $4.1 Million Public Offering
Mon, 15 May 2017 22:04:35 GMT

MabVax Therapeutics to Present Three Posters at the AACR-NCI-EORTC ...
Thu, 26 Oct 2017 11:34:14 GMT

MabVax Therapeutics Announces Uplisting to The Nasdaq Capital Market and $8 ...
Wed, 17 Aug 2016 12:00:00 GMT